Iowa’s PBM Reform Breakthrough: Inside Senate File 383 | PBM Reform with APCI
- 30m
- Transcript
Summary
Written by a model from the transcript; not yet reviewed.
This episode explores the hard-fought legislative battle behind Iowa's Senate File 383, a comprehensive pharmacy benefit manager reform law signed by Governor Kim Reynolds in June 2025. Host Todd Urey and guest Dr. Brett Barker, a pharmacist and Iowa state representative, examine how the legislation protects independent community pharmacies, bans anti-competitive steering practices, and implements a cost-plus reimbursement methodology tied to the national average drug acquisition cost. Barker shares insights from the political trenches, detailing the intense lobbying opposition from major corporate entities, the necessity of bipartisan legislative champions, and the ongoing legal battles in the Eighth Circuit.
- State lawmakers should look at successfully tested legal precedents from other jurisdictions like Arkansas when drafting aggressive PBM reform legislation. 11:55
- Unified professional advocacy across both independent and chain pharmacies is critical to overcoming well-funded industry lobbying at state capitals. 13:48
- Pharmacy students should engage in political advocacy early through events like day on the hill to build lifelong policy interest. 19:02
- State-level reforms must be prepared to survive rigorous legal challenges as PBM industry opponents litigate new statutes in federal courts. 27:48
Chapters
- 0:05Podcast Intro and Host Transition
The hosts introduce the podcast and the new host Todd Urey takes over for the episode.
- 2:13Introducing Guest Dr. Brett Barker
Todd welcomes Dr. Brett Barker, a pharmacist and Iowa state representative, to discuss his legislative work.
- 3:23Barker’s Background and Motivation
Barker explains his pharmacy education, family influences, and why he chose pharmacy.
- 4:42Iowa Senate File 383 Overview
Barker outlines the key provisions and goals of the PBM reform law and its impact on independent pharmacies.
- 5:38Legislative Journey and Challenges
Barker details the legislative process, opposition, and strategic moves that led to the bill’s passage.
- 9:57Key Provisions and Patient Impact
The discussion focuses on patient choice, transparency, reimbursement, and how the bill protects pharmacies.
- 11:39Broader State and National Implications
Barker talks about how Iowa’s bill fits into national PBM reform efforts and future federal actions.
- 15:12Advocacy and Pharmacist Involvement
The hosts emphasize the importance of pharmacist advocacy, student engagement, and building coalitions.
- 23:52Resources, Lobbying, and Future Steps
They discuss lobbying expenditures, upcoming litigation, and adjacent policy areas like 340B and Medicaid.
- 29:55Closing Remarks and Thank You
The episode concludes with gratitude to Dr. Barker and a preview of future topics.
Highlights
- 3:32
Choosing Pharmacy Without Bloodstory
The guest explains that he originally chose pharmacy to help aging grandparents and because it offered a healthcare career without blood and surgical procedures.
- 6:02
The Contentious Governor's Signaturestory
The guest reveals that Senate File 383 was one of the two most contentious bills of the session, signed by the governor on the very last allowable day.
- 9:04
Exposing Daily Financial Lossesstrategy
The guest describes graphing real pharmacy transaction data to show legislators how negative reimbursement rates lead to death by a thousand cuts.
- 9:57
The host highlights the massive scope of Iowa's PBM reform law, which stops steering, prevents exclusive mail-order mandates, and mandates NADAC plus dispensing fees.
- 11:39
The Laboratory of Democracyinsight
The guest explains how state capitals are leading the charge on PBM reform because federal action has lagged behind state-level successes.
- 14:11
Rewriting the Practice Actstrategy
The guest details Iowa's modernization of its 1984 Pharmacy Practice Act to embrace full standard of care and clinical prescriptive authority.
- 23:51
The host highlights that four major PBM entities spent a combined total of $43.7 million on lobbying efforts to block reform.
Quotes
“PBMs cannot steer patients towards a preferred affiliated network or mail order pharmacy by using different copays or reimbursement terms.”
Unnamed speaker · 10:11 “We have a cost plus methodology for, for reimbursement, kind of a NADAC plus dispensing fee model.”
Unnamed speaker · 8:23 “Pharmacists understand things, physicians understand things differently than the layperson or differently than the lawyer or someone that's in legislation, legislators throughout the country, either Senate or the House.”
Unnamed speaker · 24:39 “We have a unified profession. So when pharmacy speaks at the Capitol, it speaks for everyone.”
Unnamed speaker · 13:45
About this episode
Guest: Iowa State Representative Brett Barker, PharmD — District 51Guest Host: Todd S. Eury, Pharmacy Podcast NetworkRegular Host: Greg Reybold — on special assignmentSponsored by: American Pharmacy Cooperative, Inc. (APCI) Iowa has delivered one of the most significant state-level victories in the continuing fight for pharmacy benefit manager reform. On this episode of the PBM Reform Podcast, guest host Todd S. Eury sits down with Iowa State Representative Brett Barker, PharmD, a practicing pharmacist and representative of Iowa House District 51, for an inside look at the passage of Senate File 383 and what the new law could mean for independent pharmacies, employers, patients and the future of PBM regulation across the country. Representative Barker brings a rare perspective to the discussion. In addition to serving in the Iowa Legislature, he is a pharmacist and pharmacy executive who understands firsthand the financial pressures facing community pharmacies. Barker served as one of the House floor managers for SF 383 as the legislation moved through the Iowa General Assembly. The legislation cleared the Iowa House by a 75–15 vote after previously passing the Senate 36–14. Governor Kim Reynolds signed SF 383 into law on June 11, 2025, and its primary provisions became effective July 1, 2025. SF 383 establishes substantial new requirements governing pharmacy benefit managers and their relationships with pharmacies, health plans and other payors. Among its provisions, the law addresses PBM reimbursement practices, pharmacy contracting, pass-through pricing, pharmacy appeals and disputes, network participation and protections intended to prevent discriminatory treatment of pharmacies. One of the central themes of the legislation is greater transparency and accountability surrounding the flow of prescription-drug dollars. The law defines and establishes requirements involving pass-through pricing, in which payments made by a third-party payor to a PBM for prescription drugs correspond to payments made to the dispensing pharmacy, including applicable professional dispensing fees. During the conversation, Todd and Representative Barker explore: Why PBM reform became such an urgent issue for Iowa pharmacists and patients. What community pharmacies were experiencing financially before SF 383. How pharmacists, pharmacy owners and advocacy organizations helped educate Iowa lawmakers. The political battle surrounding the legislation and what ultimately helped generate bipartisan support. Why PBM reimbursement methodology is central to pharmacy sustainability. The importance of giving pharmacies meaningful mechanisms to challenge reimbursement and contractual disputes. The role Representative Barker's pharmacy background played in explaining PBM economics to fellow legislators. The opposition lawmakers encountered while attempting to move PBM reform forward. What other states can learn from Iowa's strategy. Why pharmacists need greater representation inside state legislatures. Whether Iowa's legislation could become a model for broader PBM reform nationwide. Governor Reynolds described the legislation as an effort to bring greater accountability to PBMs and noted when signing the bill that Iowa was joining a growing number of states pursuing similar reforms. For independent community pharmacists, the Iowa experience demonstrates something increasingly important: PBM reform is no longer simply a pharmacy reimbursement debate. It is becoming a healthcare access, competition and patient-care issue being fought state by state. Representative Barker's story also highlights another major theme of the PBM Reform Podcast — the importance of pharmacists becoming directly engaged in public policy. When pharmacists bring their clinical knowledge, business experience and patient relationships into state government, they can help lawmakers understand how policies written hundreds of miles away ultimately affect
Transcript
5,700 words · 4 speakers
Topics
- Pharmacy
- PBM
- Iowa
- PBM Reform Podcast
- Eighth Circuit
- 340B
- CVS
- Iowa Legislature
- Pharmacy Podcast Network
- Pharmacy Practice Act
Page updated · transcript and summary are machine-generated